Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Lancet (London, England)
|
June 29, 1996
Two brothers with mediastinal tumours
S Brown, J J McKendrick
Cancer
|
February 1, 1991
Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropin
J J McKendrick, J Theaker, G M Mead
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
June 13, 2003
Multiple relapses of mature teratoma, germinal and non-germ cell cancer in a patient treated with chemotherapy for testicular non-seminomatous germ cell cancer
J J McKendrick, G M Mead, D Cowlishaw
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 11, 2002
Brain as sanctuary site of relapse in germ cell cancer patients previously treated with chemotherapy
S J Crabb, J J McKendrick, G M Mead
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma
J W Sweetenham, J J McKendrick, G M Mead, et al.
International Journal of Oncology
|
January 22, 2011
The anti-leukemic effect and molecular mechanisms of novel hydroxamate and benzamide histone deacetylase inhibitors with 5-aza-cytidine
H B Liu, P A Mayes, P Perlmutter, et al.
British Journal of Cancer
|
February 1, 1990
High dose intensity combination chemotherapy for advanced epithelial ovarian carcinoma: results of a pilot study
J W Sweetenham, J J McKendrick, D H Jones, et al.
International Journal of Oncology
|
January 17, 2009
The anti-leukemic effect of a novel histone deacetylase inhibitor MCT-1 and 5-aza-cytidine involves augmentation of Nur77 and inhibition of MMP-9 expression
H B Liu, M T Voso, D Gumiero, et al.
Anti-Cancer Drugs
|
June 1, 1994
Lean body mass, body surface area and epirubicin kinetics
W C Cosolo, D J Morgan, E Seeman, et al.
European Journal of Cancer & Clinical Oncology
|
March 1, 1989
ChlVPP chemotherapy in advanced Hodgkin's disease
J J McKendrick, G M Mead, J Sweetenham, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Lancet (London, England)
|
June 29, 1996
Two brothers with mediastinal tumours
S Brown, J J McKendrick
Cancer
|
February 1, 1991
Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropin
J J McKendrick, J Theaker, G M Mead
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
June 13, 2003
Multiple relapses of mature teratoma, germinal and non-germ cell cancer in a patient treated with chemotherapy for testicular non-seminomatous germ cell cancer
J J McKendrick, G M Mead, D Cowlishaw
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 11, 2002
Brain as sanctuary site of relapse in germ cell cancer patients previously treated with chemotherapy
S J Crabb, J J McKendrick, G M Mead
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma
J W Sweetenham, J J McKendrick, G M Mead, et al.
International Journal of Oncology
|
January 22, 2011
The anti-leukemic effect and molecular mechanisms of novel hydroxamate and benzamide histone deacetylase inhibitors with 5-aza-cytidine
H B Liu, P A Mayes, P Perlmutter, et al.
British Journal of Cancer
|
February 1, 1990
High dose intensity combination chemotherapy for advanced epithelial ovarian carcinoma: results of a pilot study
J W Sweetenham, J J McKendrick, D H Jones, et al.
International Journal of Oncology
|
January 17, 2009
The anti-leukemic effect of a novel histone deacetylase inhibitor MCT-1 and 5-aza-cytidine involves augmentation of Nur77 and inhibition of MMP-9 expression
H B Liu, M T Voso, D Gumiero, et al.
Anti-Cancer Drugs
|
June 1, 1994
Lean body mass, body surface area and epirubicin kinetics
W C Cosolo, D J Morgan, E Seeman, et al.
European Journal of Cancer & Clinical Oncology
|
March 1, 1989
ChlVPP chemotherapy in advanced Hodgkin's disease
J J McKendrick, G M Mead, J Sweetenham, et al.
Page
of 2